ADVERTISEMENT

ASH 2021 - CAR T-cell therapy liso-cel improves outcomes in relapsed and refractory large B-cell lymphoma

Daniela Ovadia — Agenzia Zoe   |   Conference Report   |   15 December 2021
ADVERTISEMENT

by Massimo Sandal (Agenzia Zoe)

 

Takeaway messages

  • Interim analysis of the TRANSFORM clinical trial shows that CAR-T cell therapy can substantially increase large B-cell lymphoma (LBCL) event-free survival in refractory/relapsed patients.

Why this matters

  • Patients...

          

March Challenge

Ends in 11d 15h
left
right

Topic Challenges

left
right